OXADIAZOLE COMPOUND AND PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
申请人:SHANGHAI JIAO TONG UNIVERSITY
公开号:US20140350026A1
公开(公告)日:2014-11-27
The present invention provides an anti-Coxsackie virus oxadiazole compound as represented by formula (I), or the pharmaceutically acceptable salt thereof, a preparation method, a pharmaceutical composition, and use thereof, wherein R is CH3 or CF3; R′ and R″ are respectively H, alkyl or halogen; A is O or S; n is a number from 1 to 6; X is O, S or NH; Y is alkyl, unsubstituted cycloalkyl, mono-substituted cycloalkyl, disubstituted cycloalkyl, poly-substituted cycloalkyl, unsubstituted aryl, mono-substituted aryl, disubstituted aryl, poly-substituted aryl, unsubstituted 5-6 membered heterocyclyl, mono-substituted 5-6 membered heterocyclyl, disubstituted 5-6 membered heterocyclyl, or poly-substituted 5-6 membered heterocyclyl. Compared to prior art, the oxadiazole compound of the present invention has excellent anti-Coxsackie virus activity, lower toxicity and high safety.
本发明提供了一种抗柯萨奇病毒的噁二唑化合物,其化学式为(I)或其药学上可接受的盐,以及其制备方法、制药组合物和用途。其中,R为CH3或CF3;R'和R"分别为H、烷基或卤素;A为O或S;n为1至6的数字;X为O、S或NH;Y为烷基、未取代的环烷基、单取代的环烷基、双取代的环烷基、多取代的环烷基、未取代的芳基、单取代的芳基、双取代的芳基、多取代的芳基、未取代的5-6元杂环基、单取代的5-6元杂环基、双取代的5-6元杂环基或多取代的5-6元杂环基。与现有技术相比,本发明的噁二唑化合物具有优异的抗柯萨奇病毒活性,毒性较低,安全性高。